| 1/2 | US=25 / Mama Kumar Pal S, Pegram MD. Treatment of HER2-Overexpressing metastatic breast cancer. In: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the breast. 4ªed. Philadelphia: Lippincott Williams & Wilkins, 2010. p. 920-37. ISBN 978-0-7817-9117-5. TRATAMENTO DO CANCER DE MAMA METASTATICO; QUIMIOTERAPIA; DOSAGEM DE QUIMIOTERAPIA; TRASTUZUMAB; LAPATINIB |
| 2/2 | US=50 / Câncer Rugo HS, Lin AYJ. Targeted therapy for breast cancer: a focus on HER2/neu and antiangiogenic therapy. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 497-509. ISBN 978-1-60327-086-1. TERAPIA-ALVO PARA CANCER DE MAMA; HER2/NEU E TERAPIA ANTIANGIOGENICA; CANCER DE MAMA METASTATICO; HER2/NEU; TRASTUZUMAB; LAPATINIB; BEVACIZUMAB; SUNITINIB; ANTIANGIOGENICO; TERAPIA-ALVO |